[Etiopathogenesis of paraneoplastic hypercalcemia].
Fontaine
M A
MA
CHU, Service de Rhumatologie, Université de Liège.
Almer
S
S
Franchimont
P
P
D002118:Calcium / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D006934:Hypercalcemia / Q000503:physiopathology*; D007668:Kidney / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism; D010257:Paraneoplastic Syndromes / Q000503:physiopathology*; D010281:Parathyroid Hormone / Q000378:metabolism*; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000378:metabolism
D016207:Cytokines; D006133:Growth Substances; D009363:Neoplasm Proteins; C470121:PTHLH protein, human; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D002118:Calcium
Etiopathogénie de l'hypercalcémie paranéoplasique.